Labcorp Holdings Inc. LH, or Labcorp, is slated to report its third-quarter 2025 results on Oct. 28, before the market opens.

BURLINGTON, N.C., July 30, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Test Finder, a first-of-its-kind ...

(RTTNews) - Labcorp (LH) announced the expansion of its precision oncology portfolio. The additions include new test offerings for solid tumor and hematologic malignancies and enhanced biopharma ...

Labcorp is a global life sciences company headquartered in Burlington, North Carolina. Labcorp provides at-home test kits as well as in-person testing at their laboratory facilities, which are located ...

(Reuters) - Labcorp on Wednesday began marketing to U.S. physicians the first test for a trio of blood biomarkers it says can detect the hallmarks of Alzheimer's, accelerating diagnosis of the ...

Test is available through physicians for use with patients being evaluated for possible Alzheimer's disease or other causes of cognitive impairment Labcorp is the first company to deliver a ...

Laboratory Corporation of America Holdings, Inc., or LabCorp LH, recently launched a new, FDA-cleared blood test for risk assessment and clinical management of severe preeclampsia. The preeclampsia is ...

BURLINGTON, North Carolina -- LabCorp has received emergency use authorization from the Food and Drug Administration for its Pixel at home coronavirus test kit. The COVID-19 At Home Test Kit allows ...

Labcorp Holdings, Inc. LH has announced the nationwide availability of the Lumipulse pTau-217/Beta Amyloid 42 Ratio — the first FDA-cleared blood-based in-vitro diagnostic (IVD) test to assist in ...

A new Labcorp technique for early detection of Alzheimer’s disease for adults ages 50 and older has become available nationwide, the Burlington company announced last week. The Food and Drug ...